Evidence map›Paper›PMID 23004677›Full record

ArticleBritish journal of pharmacology2013

Protective effect of nectandrin B, a potent AMPK activator on neointima formation: inhibition of Pin1 expression through AMPK activation.

Sung Hwan Ki, Jung-Woon Lee, Sung Chul Lim, Tran Thi Hien, Ji Hye Im, Won Keun Oh, Moo Yeol Lee, Young Hyun Ji, Yoon Gyoon Kim, Keon Wook Kang

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Erratum.British journal of pharmacology · 2017
    Article
  5. Chemical diversity and pharmacological significance of the secondary metabolites of nutmeg (Phytochemistry reviews : proceedings of the Phytochemical Society of Europe · 2016
    Article
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Sung Hwan KiBK21 Project Team, College of Pharmacy, Chosun University, Gwangju, South Korea.
Jung-Woon Lee
Sung Chul Lim
Tran Thi Hien
Ji Hye Im
Won Keun Oh
Moo Yeol Lee
Young Hyun Ji
Yoon Gyoon Kim
Keon Wook Kang
Chosun University · KRDankook University · KRNew Generation University College · ETDongguk University · KRSeoul National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeNeointima is considered a critical event in the development of vascular occlusive disease. Nectandrin B from nutmeg functions as a potent AMP-activated protein kinase (AMPK) activators. The present study addressed whether nectandrin B inhibits intimal hyperplasia in guide wire-injured arteries and examined its molecular mechanism. EXPERIMENTAL APPROACH: Neointima was induced by guide wire injury in mouse femoral arteries. Cell proliferation and mechanism studies were performed in rat vascular smooth muscle cells (VSMC) culture model. KEY

resultsNectandrin B increased AMPK activity in VSMC. Nectandrin B inhibited the cell proliferation induced by PDGF and DNA synthesis. Moreover, treatment of nectandrin B suppressed neointima formation in femoral artery after guide wire injury. We have recently shown that Pin1 plays a critical role in VSMC proliferation and neointima formation. Nectandrin B potently blocked PDGF-induced Pin1 and cyclin D1 expression and nectandrin B's anti-proliferation effect was diminished in Pin1 overexpressed VSMC. PDGF-induced phosphorylation of ERK and Akt was marginally affected by nectandrin B. However, nectandrin B increased the levels of p53 and its downstream target p21 and, also reversibly decreased the expression of E2F1 and phosphorylated Rb in PDGF-treated VSMC. AMPK inhibition by dominant mutant form of adenovirus rescued nectandrin B-mediated down-regulation of Pin1 and E2F1. CONCLUSIONS AND IMPLICATIONS: Nectandrin B inhibited VSMC proliferation and neointima formation via inhibition of E2F1-dependent Pin1 gene transcription, which is mediated through the activation of an AMPK/p53-triggered pathway.

Indexed as

AMP-Activated Protein Kinase KinasesAnimalsCell ProliferationCells, CulturedEnzyme ActivationFemoral ArteryLignansMiceMuscle, Smooth, VascularNeointimaNIMA-Interacting Peptidylprolyl IsomerasePeptidylprolyl IsomeraseProtective AgentsProtein KinasesRatsVascular System InjuriesAMP-Activated Protein Kinase KinasesLignansnectandrin-BNIMA-Interacting Peptidylprolyl IsomerasePeptidylprolyl IsomerasePin1 protein, mouseProtective AgentsProtein Kinases

Identifiers

PMID23004677
PMCPMC3631381
OpenAlexW1744305815

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.